This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as a key intermediate in the creation of compounds targeting neurological and psychiatric disorders, such as anxiety and depression. Its unique spirocyclic structure makes it valuable for designing molecules that interact with specific receptors in the brain, potentially leading to improved therapeutic agents. Additionally, it is explored for its potential in modulating neurotransmitter systems, offering insights into the treatment of neurodegenerative diseases. Researchers also investigate its application in the development of prodrugs, aiming to enhance drug delivery and bioavailability.